$185,466,764

Department of Health and Human Services·Office of Assistant Secretary for Preparedness and Response

to CERUS CORPORATION

biotechactive

ACTION DATE2026-02-20·SOURCEUSASPENDING·SOURCE IDCONT_AWD_HHSO100201600009C_7505_-NONE-_-NONE-

Award description

CERUS - DEVELOPMENT AND IMPLEMENTATION OF PATHOGEN REDUCTION TECHNOLOGY (PRT). IGF::OT::IGF

Verbatim from USAspending.gov. Capitalization, abbreviations, and codes are unchanged.

The Buildout's read

What the model surfaced from this award

Confidence: high

In plain English

Develop and implement pathogen reduction technology to eliminate infectious agents in blood products for transfusion safety.

Sub-sectors

pathogen-reduction-technologyblood-safetypandemic-preparedness

Why this matters

Pathogen reduction is critical infrastructure for pandemic preparedness and protecting the U.S. blood supply from emerging infectious diseases.

Supply-chain signal

Large investment signals government commitment to domestic blood-safety technology; may drive adoption across hospital networks and blood banks.

U.S.–China competition angle

Pathogen reduction technology is a strategic capability; securing domestic development reduces reliance on foreign suppliers for pandemic-critical medical countermeasures.

Generated by award_classification v2.0.0 via claude-haiku-4-5-20251001 on 2026-05-15. Cost: $0.002188.

Period of performance

Start

2016-06-17

End

2026-09-30

Status

activein 137 days

Recipient

CERUS CORPORATION

UEI KJJQRRLY2FL5

View full profile →

Sources

USAspending.gov — all awards for this UEI →
SAM.gov entity registration →
Award record ingested from usaspending. Source identifier CONT_AWD_HHSO100201600009C_7505_-NONE-_-NONE-.

The Buildout does not edit federal records. Any inaccuracy reflects the upstream source; it will update here when corrected there.